72.46
price down icon1.39%   -1.0431
 
loading

Astrazeneca PLC Aktie (AZN) Neueste Nachrichten

pulisher
12:52 PM

AstraZeneca reports total voting rights - Investing.com

12:52 PM
pulisher
12:45 PM

Peering Into AstraZeneca's Recent Short Interest - Benzinga

12:45 PM
pulisher
10:48 AM

Baxdrostat, AstraZeneca’s Next Big CVRM Bet - insights.citeline.com

10:48 AM
pulisher
10:04 AM

AstraZeneca Announces Share Capital and Voting Rights Update - TipRanks

10:04 AM
pulisher
09:31 AM

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication - Yahoo

09:31 AM
pulisher
05:43 AM

428,441 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Brandywine Global Investment Management LLC - MarketBeat

05:43 AM
pulisher
05:04 AM

A £10,000 investment in AstraZeneca shares last Christmas is now worth… - Fool UK

05:04 AM
pulisher
04:49 AM

AstraZeneca: 'AZD0780' promising against cholesterol - MarketScreener

04:49 AM
pulisher
03:25 AM

AstraZeneca’s (AZN LN) Potential Blockbuster Pill Halves High Cholesterol - Bloomberg.com

03:25 AM
pulisher
02:49 AM

Congress Wealth Management LLC DE Raises Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat

02:49 AM
pulisher
Mar 31, 2025

FDA Approves AstraZeneca's Imfinzi As First Perioperative Immunotherapy For Muscle-Invasive Bladder Cancer Patients - AOL.com

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca Says Investigational Drug Cuts LDL Cholesterol in Phase 2b Trial - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca reports cholesterol drug success in trial By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca Oral PCSK9 Prospects Pumped After Phase IIb Win - insights.citeline.com

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca’s Calquence Nears EU Approval for Mantle Cell Lymphoma - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca's Muscle-Invasive Bladder Cancer Treatment Gets FDA Approval - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

Astrazeneca Receives Approval Recommendation for Calquence Combination Therapy in Europe - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

FDA approves AstraZeneca’s Imfinzi for bladder cancer - Investing.com

Mar 31, 2025
pulisher
Mar 31, 2025

FDA approves AstraZeneca’s Imfinzi for bladder cancer By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

FDA approves AstraZeneca’s IMFINZI for bladder cancer By Investing.com - Investing.com UK

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca makes regulatory progress with Imfinzi, Calquence - ShareCast

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca Scores Key Regulatory Wins in US, EU for Cancer Treatments - Marketscreener.com

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca PLC : A technical turn-around configuration - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca's Calquence Combo Gets Positive Opinion from EU Panel for Rare Blood Cancer - Marketscreener.com

Mar 31, 2025
pulisher
Mar 31, 2025

Astrazeneca's Calquence Recommended For EU Approval In 1L MCL - Marketscreener.com

Mar 31, 2025
pulisher
Mar 31, 2025

AstraZeneca’s Imfinzi granted FDA approval in the US for bladder cancer - DirectorsTalk Interviews

Mar 31, 2025
pulisher
Mar 31, 2025

Imfinzi by AstraZeneca gets US approval for bladder cancer treatment - Investing.com UK

Mar 31, 2025
pulisher
Mar 30, 2025

J&J Passes AstraZeneca in Lung Cancer Drug Race — For Now - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding - GlobeNewswire Inc.

Mar 29, 2025
pulisher
Mar 29, 2025

AstraZeneca Pharma India to discontinue manufacturing, marketing of angina drug from April 1 - Medical Dialogues

Mar 29, 2025
pulisher
Mar 28, 2025

AstraZeneca's Imfinzi gains additional indication for bladder cancer - Seeking Alpha

Mar 28, 2025
pulisher
Mar 28, 2025

AstraZeneca (AZN) Gains FDA Approval for New Imfinzi Indication - GuruFocus

Mar 28, 2025
pulisher
Mar 28, 2025

Is AstraZeneca (AZN) the Best ADR Stock to Buy According to Hedge Funds? - Yahoo Finance

Mar 28, 2025
pulisher
Mar 28, 2025

AstraZeneca PLC ADR outperforms competitors on strong trading day - MarketWatch

Mar 28, 2025
pulisher
Mar 28, 2025

AstraZeneca Sues Consultancy For £32M Over HQ Defects - Law360

Mar 28, 2025
pulisher
Mar 28, 2025

Goldman Sachs maintains AstraZeneca stock with $98 target By Investing.com - Investing.com UK

Mar 28, 2025
pulisher
Mar 28, 2025

Goldman Sachs lifts AstraZeneca stock target, sees growth By Investing.com - Investing.com UK

Mar 28, 2025
pulisher
Mar 27, 2025

AstraZeneca Fights Generic Diabetes Drug Launch - Law360

Mar 27, 2025
pulisher
Mar 27, 2025

Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Brokers Suggest Investing in Astrazeneca (AZN): Read This Before Placing a Bet - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Berenberg Keeps AstraZeneca at Buy on Pipeline Potential - Marketscreener.com

Mar 27, 2025
pulisher
Mar 26, 2025

Del. Justices Back Axing Suit Over $3B AstraZeneca Viela Sale - Law360

Mar 26, 2025
pulisher
Mar 26, 2025

J&J passes AstraZeneca in lung cancer drug race — for now - Crain's New York Business

Mar 26, 2025
pulisher
Mar 26, 2025

J&J’s Rybrevant-Lazcluze Combo Tops AstraZeneca’s Drug in EGFR Lung CancerJohnson & Johnson (NYSE:JNJ) - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

J&J Passes AstraZeneca in Blockbuster Cancer Race — For Now - Bloomberg

Mar 26, 2025
pulisher
Mar 26, 2025

AstraZeneca's Win in Shareholder Suit Over Viela Sale Affirmed - Bloomberg Law News

Mar 26, 2025
pulisher
Mar 26, 2025

China on track to outpace Europe in pharmaceutical innovation, says AstraZeneca CEO By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 26, 2025

China on track to outpace Europe in pharmaceutical innovation, says AstraZeneca CEO - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Europe Rapidly Falling Behind China in Pharma, AstraZeneca CEO Warns - Bloomberg

Mar 26, 2025
pulisher
Mar 26, 2025

Whittier Trust Co. Boosts Position in AstraZeneca PLC (NASDAQ:AZN) - MarketBeat

Mar 26, 2025
pulisher
Mar 25, 2025

Astrazeneca invests in China: $8B in deals, $2.5B in R&D center - BioWorld MedTech

Mar 25, 2025
pulisher
Mar 25, 2025

Astrazeneca Says Tagrisso Shows Improved Overall Survival Trend In Laura Phase 3 Trial - MarketScreener

Mar 25, 2025
pulisher
Mar 25, 2025

AstraZeneca Seeks to Move Past China Probe With R&D Hub - Bloomberg

Mar 25, 2025
pulisher
Mar 25, 2025

AstraZeneca seeks to move past China probe with Beijing R&D hub - The Edge Malaysia

Mar 25, 2025
pulisher
Mar 24, 2025

AstraZeneca PLC ADR underperforms Monday when compared to competitors - MarketWatch

Mar 24, 2025
pulisher
Mar 24, 2025

Assemblin to upgrade AstraZeneca’s Gärtuna plant in Sweden - Yahoo Finance

Mar 24, 2025
pulisher
Mar 24, 2025

AstraZeneca and GKS shares have legs, but the weight loss titans will dominate, says investment bank - Proactive Investors

Mar 24, 2025
pulisher
Mar 24, 2025

Prediction: 12 months from now, AstraZeneca’s share price could be… - Yahoo

Mar 24, 2025
pulisher
Mar 24, 2025

AstraZeneca to invest $2.5bn in R&D centre in China - Pharmaceutical Technology

Mar 24, 2025
pulisher
Mar 24, 2025

Assemblin Caverion Group Unit to Upgrade AstraZeneca's Swedish Plant -March 24, 2025 at 03:37 am EDT - MarketScreener

Mar 24, 2025
pulisher
Mar 23, 2025

Top global stories of the week: AstraZeneca, BYD, SoftBank among notable names - Seeking Alpha

Mar 23, 2025
pulisher
Mar 23, 2025

AstraZeneca | Pharmaceuticals, Vaccines, & Facts - Britannica

Mar 23, 2025
pulisher
Mar 21, 2025

AstraZeneca Expands Emphasis On China, Already A Key Market - Citeline

Mar 21, 2025
Kapitalisierung:     |  Volumen (24h):